
Ending the ‘Pill Penalty’ Costly for CMS and Medicare Beneficiaries, Say Harvard Researchers
The Inflation Reduction Act (IRA) exempts biologics from CMS price negotiation for 13 years and small molecules for nine. The pharmaceutical industry has been pushing for a change that would give small molecules and biologics the same 13-year exemption. A …